CNBCJohnson & Johnson stock jumps 8% after it says human testing of its coronavirus vaccine to begin by SeptemberMar 30, 2020more_vert
PR NewswireJohnson & Johnson Announces a Lead Vaccine Candidate for COVID-19; Landmark New Partnership with U.S. ...Mar 30, 2020more_vert
ForbesJohnson & Johnson Is Already Ramping Up Production On Its $1 Billion Coronavirus VaccineMar 30, 2020Thomas BrewsterBy Thomas Brewstermore_vert
TechCrunchJohnson & Johnson partners with BARDA to fund $1 billion in COVID-19 vaccine researchMar 30, 2020Jonathan ShieberBy Jonathan Shiebermore_vert
ForbesThe U.S. Just Signed A $450 Million Coronavirus Vaccine Contract With Johnson & JohnsonMar 30, 2020Thomas BrewsterBy Thomas Brewstermore_vert